Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Feedburner
Share Us

Latest Guidelines for Combination Products Registration - 2017

View: 70

Website http://www.compliance4all.com/control/w_product/~product_id=501314LIVE?channel=ourglocal_Jul_2017_SE | Edit Freely

Category Combination Products Registration, Regulatory Affairs, Pharmaceutical Webinars, combination products conference 2017, combination products fda, combination products EU, combination products guidance fda

Deadline: July 09, 2017 | Date: July 10, 2017

Venue/Country: Online, U.S.A

Updated: 2017-05-16 20:24:03 (GMT+9)

Call For Papers - CFP

Overview:

During this introductory session, delegates will gain a complete guide to the status and impact of the latest guidelines for combination products.

Why should you Attend:

This webinar will examine the regulatory requirements for drug device combinations in the case of a drug and a device and for integral products.This webinar will cover the basic requirements of how to stay compliant.

Areas Covered in the Session:

Interfacing,Development,Quality,Regulatory

Managing third parties and document control

Vigilance and adverse event reporting

Who Will Benefit:

Regulatory Affairs

Medical Officers

Speaker Profile:

Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH.

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: support@compliance4All.com


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.